Literature DB >> 4705415

Pathologic patterns of chronic obstructive pulmonary diseases in patients with normal and deficient levels of alpha 1 antitrypsin.

R E Kanner, M R Klauber, S Watanabe, A D Renzetti, A Bigler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4705415     DOI： 10.1016/0002-9343(73)90056-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.

Authors:  James K Stoller; Loutfi S Aboussouan; Richard E Kanner; Laura A Wilson; Phil Diaz; Robert Wise
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 2.  Alpha1-antitrypsin.

Authors:  F Kueppers
Journal:  Am J Hum Genet       Date:  1973-11       Impact factor: 11.025

3.  Pathogenesis of emphysema.

Authors: 
Journal:  Br Med J       Date:  1974-03-23

4.  Adult alpha1-antitrypsin deficiency.

Authors:  E C Sweeney
Journal:  J Clin Pathol       Date:  1975-08       Impact factor: 3.411

Review 5.  Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population.

Authors:  R B Cole; N C Nevin; G Blundell; J D Merrett; J R McDonald; W P Johnston
Journal:  Thorax       Date:  1976-04       Impact factor: 9.139

6.  Regional distribution of ventilation and perfusion in patients with obstructive pulmonary disease and alpha 1-antitrypsin deficiency.

Authors:  A B Mostafa; N J Tulley; L K Harding; R A Stockley
Journal:  Eur J Nucl Med       Date:  1983

7.  alpha 1-Antitrypsin deficiency and susceptibility to lung disease.

Authors:  H E Evans; N Bognacki
Journal:  Environ Health Perspect       Date:  1979-04       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.